General Statement of Disclosure: CONSULTING FEES/HONORARIA: XyloCor(MODEST) RESEARCH/RESEARCH GRANTS: CSL Behring (SIGNIFICANT), Biocardia(SIGNIFICANT) OTHER FINANCIAL BENEFIT: Elsevier (SIGNIFICANT) View Full Disclosure